XML 43 R32.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Basis of Presentation and Summary of Significant Accounting Policies - Restructuring Charges (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | ---
Mar. 31, 2024 | Dec. 31, 2023 | Sep. 30, 2022 | Mar. 31, 2024 | Jun. 30, 2023 | Jun. 30, 2023
Restructuring costs, net of adjustments | $ 1,550 |  |  | $ 12,974 |  |
Accrued restructuring actions balances | 3,761 |  |  |  |  |
Restructuring costs | 1,273 | $ 11,424 |  |  |  |
Cash payments | (3,239) | (1,434) |  |  |  |
Non-cash adjustments | (843) | (6,229) |  |  |  |
Adjustments | 277 |  |  |  |  |
Accrued restructuring actions balances | 1,229 | 3,761 |  | 1,229 |  |
Corporate |  |  |  |  |  |
Restructuring costs, net of adjustments | 253 |  |  | 1,478 |  |
Diagnostics and Genomics |  |  |  |  |  |
Restructuring costs, net of adjustments | 355 |  |  | 1,094 |  |
Protein Sciences |  |  |  |  |  |
Restructuring costs, net of adjustments | 942 |  |  | 10,402 |  |
Protein Sciences | QT Holdings Corporation |  |  |  |  |  |
Restructuring costs |  |  | $ 2,170 |  |  |
Cash payments |  |  |  |  | $ (2,005) |
Adjustments |  |  |  |  | (165) |
Cost of Sales |  |  |  |  |  |
Restructuring costs, net of adjustments | 647 |  |  | 1,821 |  |
Selling, General and Administrative Expenses |  |  |  |  |  |
Restructuring costs, net of adjustments | 903 |  |  | 11,153 |  |
Selling, General and Administrative Expenses | Protein Sciences | QT Holdings Corporation |  |  |  |  |  |
Restructuring costs |  |  |  |  |  | $ 2,170
Employee severance |  |  |  |  |  |
Restructuring costs, net of adjustments | 410 |  |  | 5,292 |  |
Accrued restructuring actions balances | 3,625 |  |  |  |  |
Restructuring costs | 133 | 4,882 |  |  |  |
Cash payments | (2,806) | (1,257) |  |  |  |
Adjustments | 277 |  |  |  |  |
Accrued restructuring actions balances | 1,229 | 3,625 |  | 1,229 |  |
Employee severance | Corporate |  |  |  |  |  |
Restructuring costs, net of adjustments | 117 |  |  | 1,310 |  |
Employee severance | Diagnostics and Genomics |  |  |  |  |  |
Restructuring costs, net of adjustments | 265 |  |  | 1,004 |  |
Employee severance | Protein Sciences |  |  |  |  |  |
Restructuring costs, net of adjustments | 28 |  |  | 2,978 |  |
Accrued restructuring actions balances |  |  |  | 897 |  |
Restructuring costs |  |  |  |  |  | 1,677
Cash payments |  |  |  | (1,006) |  | (762)
Adjustments |  |  |  | 221 |  | 18
Accrued restructuring actions balances | 112 |  |  | 112 | 897 | 897
Employee severance | Protein Sciences | QT Holdings Corporation |  |  |  |  |  |
Restructuring costs |  |  | 1,328 |  |  |
Cash payments |  |  |  |  | (1,233) |
Adjustments |  |  |  |  | (95) |
Employee severance | Selling, General and Administrative Expenses | Protein Sciences | QT Holdings Corporation |  |  |  |  |  |
Restructuring costs |  |  |  |  |  | 1,328
Asset-related and other |  |  |  |  |  |
Restructuring costs, net of adjustments | 1,140 |  |  | 1,644 |  |
Accrued restructuring actions balances | 136 |  |  |  |  |
Restructuring costs | 1,140 | 504 |  |  |  |
Cash payments | (433) | (177) |  |  |  |
Non-cash adjustments | (843) | (191) |  |  |  |
Accrued restructuring actions balances |  | 136 |  |  |  |
Asset-related and other | Corporate |  |  |  |  |  |
Restructuring costs, net of adjustments | 136 |  |  | 168 |  |
Asset-related and other | Diagnostics and Genomics |  |  |  |  |  |
Restructuring costs, net of adjustments | 90 |  |  | 90 |  |
Asset-related and other | Protein Sciences |  |  |  |  |  |
Restructuring costs, net of adjustments | $ 914 |  |  | 1,386 |  |
Impairment of assets held-for-sale |  |  |  |  |  |
Restructuring costs, net of adjustments |  |  |  | 6,038 |  |
Restructuring costs |  | 6,038 |  |  |  |
Non-cash adjustments |  | $ (6,038) |  |  |  |
Impairment of assets held-for-sale | Protein Sciences |  |  |  |  |  |
Restructuring costs, net of adjustments |  |  |  | $ 6,038 |  |
Asset impairment and other | Protein Sciences | QT Holdings Corporation |  |  |  |  |  |
Restructuring costs |  |  | $ 842 |  |  |
Cash payments |  |  |  |  | (772) |
Adjustments |  |  |  |  | $ (70) |
Asset impairment and other | Selling, General and Administrative Expenses | Protein Sciences | QT Holdings Corporation |  |  |  |  |  |
Restructuring costs |  |  |  |  |  | $ 842

X
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan for the current period, net of adjustments. + References No definition available. + Details
Name: | tech_RestructuringCostsNetOfAdjustments
Namespace Prefix: | tech_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 17 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17 + Details
Name: | us-gaap_PaymentsForRestructuring
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482047/420-10-45-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 5.P.3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1 + Details
Name: | us-gaap_RestructuringCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2 + Details
Name: | us-gaap_RestructuringReserveAccrualAdjustment1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph 210-10-S99-1(SX 210.5-02(24)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_RestructuringReserveNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of decrease in the reserve for full or partial settlement through consideration other than cash. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2 + Details
Name: | us-gaap_RestructuringReserveSettledWithoutCash2
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=tech_DiagnosticsAndGenomicsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=tech_ProteinSciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=tech_QTHoldingsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringCostAndReserveAxis=tech_AssetRelatedAndOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringCostAndReserveAxis=tech_ImpairmentOfAssetsHeldForSaleMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringCostAndReserveAxis=tech_AssetImpairmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |